Search Results

240 results for michael shulman

Make Big Profits During Bad Times

By Michael Shulman, Editor, Options Income Blueprint

Playing the short side with puts is an exciting adventure that is actually independent of how the market performs, as we’ve made short-side profits on…

5 Bargain Biotech Stocks to Buy

By Michael Shulman, Editor, Options Income Blueprint

The biotech stocks on this list are speculative investments that could deliver huge returns.

Don’t Let Optimistic Analysts Lead You Off a Cliff

By Michael Shulman, Editor, Options Income Blueprint

Long-only money managers are urging investors to play the coming bottom. Before you become a lemming, check out this S&P math.

8 Explosive Option Trades

By OptionsZone Experts

We’ve put together a list of rocket-fueled options trades designed to light up your portfolio.

10 Things You MUST Know Before Shorting a Stock

By Michael Shulman, Editor, Options Income Blueprint

Don’t even think about shorting a stock before you read this.

5 Reasons You Should Love Bernanke

By Michael Shulman, Editor, Options Income Blueprint

The Federal Reserve’s quantitative easing program has been widely criticized by opponents who are portraying Fed Chairman Ben Bernanke as public enemy No. 1.

6 Retail Stocks Propelled By the ‘New Frugal’

By Traders Reserve

U.S. consumers have money to spend on retail, and they are spending it more wisely. The “New Frugal” explains why these 6 stocks have flourished…

The Obama Bounce Trade: Here Today, Gone Tomorrow

By Michael Shulman, Editor, Options Income Blueprint

When the election euphoria ends, the markets and investors have to face reality about the economy.

Top 9 Stocks to Trade This Fall

By OptionsZone Experts

If September is anything like August, stockholders are in for some hefty gains. Get this fall’s best stocks to trade.

10 Summer Blockbuster Options Trades

By OptionsZone Experts

These options trades are sure to be the summer’s smash hits.

10 Stocks ‘On the Bubble’ to Trade

By OptionsZone Experts

Trade with the momentum created by a bubble -– either on the long side in a company that was blown up, for no reason, with…

Top 9 Stocks to Trade This Fall

By

If September is anything like August, stockholders are in for some hefty gains. Get this fall’s best stocks to trade here.

Write Puts to Get Long a Stock

By Michael Shulman, Editor, Options Income Blueprint

Learn how being “assigned” to buy stock can be a reward for employing a smart strategy.

5 Scary Stocks to Short

By Michael Shulman, Editor, Options Income Blueprint

You should be afraid to have these stocks in your portfolio unless you plan to short them.

12 Commodity Bargain Trades

By OptionsZone Experts

Commodities are back in the market’s spotlight, as demand for metals, crude oil and other materials are once again on the rise.

6 Options for a Hot Summer Break

By OptionsZone Experts

Six option trades for a hot summer including McDonald’s (NYSE: MCD), IBM Corp. (NYSE: IBM) and Caterpillar (NYSE: CAT).

7 Back-to-School Option Trades

By OptionsZone Experts

Find out how to cash in on the second most important retail season of the year.

6 Top Options Trades for Q4

By OptionsZone Experts

Gear up for the fourth quarter with these options trading picks.

Outlook Still Dismal for Europe’s Banks

By Traders Reserve

Walking and talking with people in London for the Olympics one finds concern over the eurozone economies and a chance to take advantage with puts…

Double That Dividend – Sell a Call

By Michael Shulman, Editor, Options Income Blueprint

An options selling strategy could be a great way to leverage your income on Enerplus (ERF), which already yields 6% in dividends.

How to Trade the iPad Air Announcement

By Michael Shulman, Editor, Options Income Blueprint

Now that that the immediate trading frenzy has settled from the iPad Air announcement, there are still ways to trade the news this week.

AbbVie’s August Options Are a Steal

By Michael Shulman, Editor, Options Income Blueprint

Options traders should take a longer-term tack with Abbott Labs spinoff AbbVie. Here are a couple options that look like compelling values.

Profit From Volatility in Gilead and Celgene

By Michael Shulman, Editor, Options Income Blueprint

The stocks popped Monday on good drug trials — but these stocks should be on your radar for regular income through selling overheated puts.

The Way to Trade Greek Democracy

By Michael Shulman, Editor, Options Income Blueprint

While Greece asks its people to vote on a bailout, there are several short-term trades we can make right now to profit from the market-wide…

4 – 10 of 240 results